Low-Dose Trans-Resveratrol Ameliorates Diabetes-Induced Retinal Ganglion Cell Degeneration via TyrRS/c-Jun Pathway. Xiao K, Ma XH, Zhong Z, Zhao Y, et al. Invest Ophthalmol Vis Sci 2023;64:2.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xiao K, Ma XH, Zhong Z, Zhao Y, et al. Low-Dose Trans-Resveratrol Ameliorates Diabetes-Induced Retinal Ganglion Cell Degeneration via TyrRS/c-Jun Pathway. Invest Ophthalmol Vis Sci 2023;64:2.
PMID: 37261387